
Opinion|Videos|February 4, 2026
Amy Luckenbaugh, MD, reflects on patient resilience, GU oncology advances for World Cancer Day
Author(s)Amy N. Luckenbaugh, MD
Fact checked by: Hannah Clarke
Amy N. Luckenbaugh, MD, FACS, shares what her patients have taught her about resilience as well as some of the advances in urologic oncology that are giving her hope.
Advertisement
In recognition of World Cancer Day on February 4, 2026, Amy N. Luckenbaugh, MD, FACS, shares what her patients have taught her about resilience as well as some of the advances in urologic oncology that are giving her hope. Luckenbaugh is a urologic oncology at Vanderbilt University Medical Center in Nashville, Tennessee.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Vanquish Water Vapor System used in first commercial prostate ablation
2
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
3
EU agency recommends expanded approval of niraparib/abiraterone dual tablet in mHSPC
4
Treatment Patterns in Advanced Prostate Cancer from Monotherapy to Treatment Intensification
5






